Priscill&i.are implicated in two diterent clinical disease syndromes, acute and chronik Q fever, respectively. We compared the efficacies of rifampin, doxycycline, and five 4-quinolone compounds (ciprofloxacin, difloxacin, ofloxacin, norfloxacin, and pefloxacin) in reducing persistent C. burnetii infection of L929 fibroblasts. In persistently infected cells, the Priscilla isolate was less susceptible to all antibiotics tested when compared with the Nii,e Mile isolate. The most effective antibiotics against the Priscilla isolate were ofloxacin, pefloxacin, and ciprofloxacin (50% inhibitory concentrations of 0.5, 2.2, and 2.5 ,ug/ml, respectively). In persistently infected cells, the Nine Mile isolate was highly susceptible to all antibiotics tested except doxycycline. In contrast, the Priscilla and Nine Mile isolates in recently infected cells were somewhat susceptible to doxycycline; the Priscilla isolate was significantly more susceptible to ofloxacin and rifampin in recently infected host cells than in persistently infected cells. Persistently infected L929 cells were also treated with antibiotic combinations. Although ciprofloxacin and doxycycline had no synergistic effect on the Priscilla isolate, ciprofloxacin and rifampin acted synergistically. Collectively, these in vitro results are in accord with the fact that chronic Q fever in humans is generally not successfully managed with antibiotics. They also indicate that early diagnosis may be essential and that combination antibiotic therapy that includes quinolones may be effective in treating chronic Q fever.
Coxiella burnetii is an obligate intracellular procaryotic parasite of eucaryotic cells (2) . This bacterium is the etiologic agent of Q fever, a disease that typically causes an acute, febrile illness (2, 4, 5) . In addition to causing acute disease, C. burnetii occasionally causes life-threatening chronic, relapsing endocarditic infections in humans which may involve aortic and mitral valves (16, 22, 25, 26) . These two distinct disease syndromes have been attributed to the condition of the patient (22, (24) (25) (26) : noncompromised or compromised patients are, in general, observed to suffer from acute or chronic Q-fever syndrome, respectively (22, 24, 26) . Although chronic Q fever occurs more frequently in compromised patients, it has been thought to be the result of patient predisposition rather than a particular characteristic of the pathogen causing the infection. However, recent studies have demonstrated that the C. burnetii isolates associated with acute and chronic Q fever are genetically distinct (21) . The Priscilla isolate of C. buirnetii was found to contain a plasmid (designated QpRS) 2 to 3 kilobases larger than the distinct plasmid (QpH1) found in the Nine Mile isolate (21) . Examination of over 20 C. burnetii isolates has resulted in the discovery of three general groups, one containing the QpRS-type plasmid, a second containing the QpH1-type plasmid, and a third lacking plasmids. Based on the original source, it was noted that QpRS-containing and plasmidless isolates were associated with chronically infected patients and animals, and isolates containing the QpH1-type plasmid were derived from acutely infected patients and animals. Moreover, studies comparing the virulence of the Nine Mile (acute) and Priscilla (chronic) isolates of C. burnetii suggest that differences in the compo-* Corresponding author.
sition and antigenicity of their surface lipopolysaiccharides may account for differences in pathogenicity (14) .
Antibiotic management of acute Q fever is generally successful in noncompromised patients, whereas antibiotic management of chronic Q-fever endocarditis or hepatitis is poor at best (7, 11, 18, 22, 23, 25, 27) . In light of these observations, we have previously demonstrated that rifampin and several 4-quinolone antibiotics (ciprofloxacin, difloxacin, and oxolinic acid) are highly effective in reducing persistent in vitro infections caused by Nine Mile C. burnetii (28) . In this report we show that isolates implicated in distinct clinical syndromes-acute and chronic infectionexhibit differential susceptibility to antibiotics, are more susceptible to antibiotics in early stages of persistent infection (less than 30 days), and may be more successfully managed by using antibiotics in combination.
MATERIALS AND METHODS
Source and in vitro propagation of C. burnetii infected flask, a total of 300 cells were examined each time the flasks, were sampled. All experiments were performed with concurrent, duplicate cultures so that the comparisons made would be those observed under identical culture conditions. In all experiments performed, the viabilities of treated and control infected L929 cell populations were greater than 95%. The maximum antibiotic concentrations used were 5 ,ug/ml (the 4-quinolones), 1.0 ,ug/ml (rifampin), and 20 ,ug/ml (doxycycline). These experimental antibiotic concentrations were used because (with the exception of doxycycline) they had previously been shown to be effective in controlling the Nine Mile isolate (28). Previously we reported that doxycycline at a concentration of 10 ,ug/ml was only somewhat effective in reducing Nine Mile C. burnetii infection in L929 cells (28) ; therefore, a maximum concentration of 20 ,ug/ml was used in these studies. In addition, the concentrations of antibiotics used approach the upper range of physiological levels observed in vivo (10) .
Comparison of the effect of antibiotics on the Priscilla and Nine Mile isolates within persistently infected cells. The efficacies of all antibiotics tested in the control of both C. burnetii isolates are summarized in Table 1 . As in our previous report (28) , the 4-quinolone antibiotics ciprofloxacin and difloxacin were highly efficacious against the Nine Mile isolate. In addition, the 4-quinolone compounds ofloxacin, pefloxacin, and norfloxacin were highly effective against the Nine Mile isolate (IC90s of 0.7, 1.4, and 4.6 pug/ml, respectively). Rifampin was the most efficacious drug against Nine Mile C. burnetii, having an IC90 lower than 0.1 ,ug/ml. Doxycycline produced only moderate reduction of infection even at 20 ,ug/ml. In contrast, the Priscilla isolate exhibited a significantly lower susceptibility to all antibiotics tested. The most effective drug in reducing Priscilla persistent infection was ofloxacin, followed distantly by pefloxacin, norfloxacin, and ciprofloxacin (IC50s of 0.5, 2.2, 2.4, and 2.5 ,ug/ml, respectively). Difloxacin was the least effective quinolone antibiotic against the Priscilla isolate, achieving neither 50 nor 90% inhibition at the maximum concentration tested. Neither rifampin nor doxycycline treatment of Priscilla isolate-infected cells resulted in 50% reduction of infection at the maximum concentrations tested (reductions of 40 and 19%, respectively). No of antibiotics against the Priscilla agent are therefore stated as being not achievable with the maximum antibiotic concentration tested. A summary of the IC50s and IC90s of all antibiotics tested against the two persistently infecting C. burnetii isolates is shown in Table 2 . Clearly, the Priscilla isolate is much less susceptible to antibiotics that are highly effective in reducing the level of persistent infection caused by the Nine Mile isolate. Results from this study lend support to our previous report (28) that, at the concentrations tested, the quinolone antibiotics are apparently rickettsicidal. This can be concluded from the fact that the reductions in percentage of infection observed within quinolone-treated persistently infected cells occurred at rates that exceed the rates of reduction that would have been observed in the case of mere dilution of statically inhibited rickettsiae through the process of host cell division.
Comparison of the effect of antibiotics on the Priscilla and Nine Mile isolates within recently infected cells. L929 cells recently infected (22 days) with either the Priscilla or Nine Mile isolate of C. burnetii were exposed to antibiotics to determine whether they exhibited antibiotic susceptibilities that were different from those of their counterparts in persistently infected cells. Our results (Table 3) show that both C. burnetii isolates in recently infected cells (<30 days) were significantly more susceptible to ofloxacin, rifampin, and even doxycycline than were their persistently infecting counterparts (>400 days); this was especially true of the Priscilla isolate.
Combination antibiotic treatment. Antibiotics having different targets were paired for experimentation aimed at revealing possible synergy in the control of persistent infection of L929 cells by both isolates of C. burnetii. The antibiotics used had been previously demonstrated to be at least somewhat effective in controlling the Nine Mile C. burnetii isolate in vitro (28) . Ciprofloxacin-rifampin (10:1) and ciprofloxacin-doxycycline (1:2) were used in combination at concentrations that were previously shown to be effective (28) . The combination of doxycycline and ciprofioxacin did not result in synergy when tested against the Priscilla isolate (Fig. 1) . However, when ciprofloxacin and rifampin were combined (10:1), synergistic effects were seen in the reduction of infection caused by the Priscilla isolate ( Fig. 2 and 3) . Independently, ciprofioxacin and rifampin resulted in the reduction of Priscilla-infected cells by 36 and 10%o, respectively; in combination, however, they caused a 91% reduction. None of the antibiotic combinations produced synergistic effects on the Nine Mile isolate. In fact, doxycycline and rifampin apparently delayed the effect of ciprofioxacin during the first 5 days of treatment (data not shown). DISCUSSION C. burnetii, the etiologic agent of Q fever, was until recently thought to be monogenotypic: acute and chronic disease syndromes were presumed to be the result of patient predisposition (22, 25, 27) . Recent evidence shows distinct plasmid and lipopolysaccharide differences between isolates of C. burnetii derived from animals and humans (14, 21) . Other workers have demonstrated the Nine Mile and Priscilla isolates to be equally infectious but different in their abilities to induce fever in laboratory animals (14) . Collectively, these data support the hypothesis (21) that different isolates may be implicated in different disease manifestations such as acute or chronic Q fever. Our current studies indicate that, in addition to exhibiting genotypic and surface antigenic differences, the two C. burnetii isolates under investigation, Nine Mile and Priscilla, also exhibit differences in antibiotic susceptibility. The observation that the Nine Mile isolate, implicated as a cause of acute Q fever, was highly susceptible to a broad range of antibiotics correlates with the apparent clinical success observed in the treatment of primary acute Q fever (28) . In contrast, the Priscilla isolate, implicated as a cause of chronic Q fever in goats (21)-and possibly humans-exhibited significant resistance to all antibiotics that were effective against the Nine Mile isolate. This observation is in agreement with the fact that chronic Q fever in humans, including Q-fever endocarditis, is not successfully managed with either antibiotic treatment or a combination of antibiotic treatment and surgical procedures (7, 18, 22, 24, 26, 27) .
The underlying causes of the antibiotic susceptibility differences between the Nine Mile and Priscilla isolates observed in these studies remain to be determined; however, there are several possibilities that are now being examined in our laboratory. There is no common characteristic of the drugs that are effective against the Nine Mile isolate but ineffective against the Priscilla isolate; doxycycline, rifampin, and the quinolones bind to different targets, directly affect different processes, are not strikingly similar in structure or charge, and appear to enter bacteria by different means.
Decreased susceptibility to the antibiotics by the Priscilla isolate may be due to an alteration in the target of the drugs. For example, a mutation within the alpha subunit protein of DNA gyrase (topoisomerase II) could result in decreased binding of the quinolone antibiotics and thus a decreased inhibition of DNA-related metabolism. A similar explanation may account for the resistance of the Priscilla isolate to rifampin, due to a possible alteration of the beta subunit of the core bacterial RNA polymerase enzyme (13) . Mutation within the gene encoding the beta subunit may lead to a decreased affinity for the binding of rifampin and thereby a lessened inhibitory effect. Rifampin and the quinolones may be especially susceptible to resistance via this mechanism due to their very specific binding affinities. In our studies we found that the Priscilla isolate exhibited an increased resistance to both the 4-quinolones and rifampin. In terms of statistical probability, it would be very unlikely that the Priscilla isolate concurrently possesses distinct mutations in the genes encoding DNA gyrase and DNA-dependent RNA polymerase (alpha and beta subunits, respectively). Therefore, it is likely that these antibiotics are resisted via one or more other mechanisms.
The unique plasmid in the Priscilla isolate may play a role in resistance; however, that remains to be determined. The plasmid may encode enzymes that act upon one or more antibiotics, resulting in their inactivation. However, the broad-scale differences in antibiotic susceptibilities between the Nine Mile and Priscilla isolates would suggest that this possible enzyme-mediated antibiotic inactivation is not the sole mechanism by which the Priscilla isolate may resist antibiotics. Another means by which the Priscilla isolate may resist antibiotics is through an alteration of its cell cycle, resulting in a prolonged growth rate and a less pronounced effect than that on rapidly growing cells. In addition, because of rapid half-life decay of many antibiotics, the chance of inhibiting sensitive processes in slowly growing organisms is diminished.
Because of the broad-scale nature of antibiotic resistance in the Priscilla isolate and the fact that the unique Priscilla plasmid possesses only 2 to 3 kilobase pairs more DNA than does the Nine Mile plasmid, it is unlikely that several distinct resistance mechanisms are encoded within its plasmid. Another explanation for the general resistance to antibiotics in the Priscilla isolate may be decreased permeability. Nalidixic acid, tetracyclines, aminoglycosides, and various other antibiotics are often resisted by bacteria whose membrane structure has a lessened permeability to one or more antibiotics (3, 6, 17 (12, 19) . A related possibility for antibiotic resistance may result from a change in permeability within the Priscilla isolate, which may lead to an increased efflux of antibiotics when concentrations within the organism reach levels sufficient to induce one or more specific antibiotic export systems. Escherichia coli possesses such an inducible tetracycline export system (3) .
The use of antibiotics in treating patients with Q-fever endocarditis has been relatively unsuccessful (7, 18, 22, 24, 26, 27 
